(Q40936303)

25 September 2017

title

Interferon-Mediated Cytokine Induction Determines Sustained Virus Control in Chronic Hepatitis C Virus Infection (English)

1 reference

25 September 2017

1 reference

5

Michael P Manns

1 reference

25 September 2017

2

Christine S Falk

1 reference

25 September 2017

Franziska Wandrer

1

1 reference

25 September 2017

Katharina John

3

1 reference

25 September 2017

Britta Skawran

4

1 reference

25 September 2017

Klaus Schulze-Osthoff

6

1 reference

25 September 2017

Heike Bantel

7

1 reference

25 September 2017

language of work or name

English

0 references

publication date

26 October 2015

1 reference

Journal of Infectious Diseases

25 September 2017

published in

1 reference

25 September 2017

volume

213

1 reference

25 September 2017

issue

5

1 reference

25 September 2017

page(s)

746-754

1 reference

Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV505

Hepatitis C virus-associated cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV505

Apoptosis in hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV505

Caspase activation correlates with the degree of inflammatory liver injury in chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV505

Detection of apoptotic caspase activation in sera from patients with chronic HCV infection is associated with fibrotic liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV505

Caspase activation is required for antiviral treatment response in chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV505

Death receptor-mediated apoptosis and the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV505

Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV505

Role of Fas ligand in apoptosis induced by hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV505

TRAIL and its receptors in the colonic epithelium: a putative role in the defense of viral infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV505

Increased hepatotoxicity of tumor necrosis factor-related apoptosis-inducing ligand in diseased human liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV505

Hepatocyte expression of TRAIL pathway regulators correlates with histopathological and clinical parameters in chronic HCV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV505

TRAIL enhances apoptosis of human hepatocellular carcinoma cells sensitized by hepatitis C virus infection: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV505

Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: A novel mechanism for the antitumor effects of type I IFNs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV505

Interferon-alpha-induced TRAIL on natural killer cells is associated with control of hepatitis C virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV505

Interferon-γ mediates chemokine-dependent recruitment of natural killer cells during viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV505

Regulation of type I interferon responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV505

Interferon signaling in the liver during hepatitis C virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV505

Nonlinear partial differential equations and applications: Genomic analysis of the host response to hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV505

Interferon signaling and treatment outcome in chronic hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV505

Endogenous intrahepatic IFNs and association with IFN-free HCV treatment outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV505

Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV505

An effective interferon-gamma-mediated inhibition of hepatitis C virus replication by natural killer cells is associated with spontaneous clearance of acute hepatitis C in human immunodeficiency virus-positive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV505

Early changes in interferon signaling define natural killer cell response and refractoriness to interferon-based therapy of hepatitis C patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV505

Interferon-alpha enhances TRAIL-mediated apoptosis by up-regulating caspase-8 transcription in human hepatoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV505

Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV505

Early changes in natural killer cell function indicate virologic response to interferon therapy for hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV505

Innate and adaptive immune responses in HCV infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV505

Natural killer cells and hepatitis C: action and reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV505

IFNgamma sensitizes for apoptosis by upregulating caspase-8 expression through the Stat1 pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV505

Expression of the chemokine IP-10 (CXCL10) by hepatocytes in chronic hepatitis C virus infection correlates with histological severity and lobular inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV505

Association of pretreatment serum interferon inducible protein 10 levels with sustained virological response to peginterferon plus ribavirin therapy in genotype 1 infected patients with chronic hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV505

IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV505

Interferon-induced gene expression is a stronger predictor of treatment response than IL28B genotype in patients with hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV505

CXCL9 associated with sustained virological response in chronic hepatitis B patients receiving peginterferon alfa-2a therapy: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV505

Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV505

Altered interferon-alpha-signaling in natural killer cells from patients with chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV505

Interferon-γ-stimulated genes, but not USP18, are expressed in livers of patients with acute hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV505

Pegylated IFN-α regulates hepatic gene expression through transient Jak/STAT activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV505

Double-stranded RNA-dependent protein kinase activates transcription factor NF-kappa B by phosphorylating I kappa B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV505

Crosstalk in NF-κB signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV505

Identification of a novel pro-apoptotic role of NF-κB in the regulation of TRAIL- and CD95-mediated apoptosis of glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV505

Role of nuclear factor-kappaB in the antiviral action of interferon and interferon-regulated gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV505

Requirement of c-Jun NH2-terminal kinase activation in interferon-alpha-induced apoptosis through upregulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in Daudi B lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV505

Regulation of the human TRAIL gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV505

21 January 2018

Identifiers

DOI

10.1093/INFDIS/JIV505

1 reference

25 September 2017

1 reference